Adenocarcinomas of the Gastroesophageal Junction
3 clinical trials · Condition
◉ Watch Adenocarcinomas of the Gastroesophageal Junction
| Record | Firm | Date |
|---|---|---|
| Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal Adenocarcinoma (NCT01182610) | Accelerated Community Oncology Research Network | 2011-04-01 |
| Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy (NCT01129206) | Ohio State University Comprehensive Cancer Center | 2010-07-01 |
| Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation. (NCT00216008) | H. Lee Moffitt Cancer Center and Research Institute | 2005-07-01 |
Track Adenocarcinomas of the Gastroesophageal Junction automatically
Every clearance here is in the API, with alerts when new ones post.